Please assess the completion status of the following clinical trial:

Trial Title: Randomized, Double-blind, Placebo-controlled Study to Assess Fatigue in Patients With ACD Due to RA Receiving PROCRIT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients must have rheumatoid arthritis with chronic anemia. Patients must have signed an informed consent~* women must be postmenopausal for at least one year, surgically sterile, or practicing an effective method of birth control, or have a negative serum pregnancy test~* women must not be breast feeding during this study period.~Exclusion Criteria:~* Uncontrolled hypertension~* elective surgery, including joint replacement, anticipated to require transfusion during the extension study period~* thromboembolic event during the double-blind study including acute myocardial infarction, cerebrovascular accident and/or transient ischemic attack~* deep vein thrombosis and/or pulmonary embolism~* uncontrolled psychiatric disease~* planning to be enrolled in any other clinical trial during the course of this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).